ArticleBriefings in bioinformatics2025
Identifying novel therapeutic targets of natural compounds in traditional Chinese medicine herbs with hypergraph representation learning.
Article in Briefings in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Metapath2vec and attention-driven heterogeneous graph learning for prioritizing TCM-derived small molecules in gastric cancer.Chinese medicine · 2026Article
- GHF-ACL: A novel contrastive learning framework with multi-order graph structures for herb-disease association prediction.PLoS computational biology · 2026Article
- Machine Learning Approaches for Compound-Target Interaction Prediction: A Review.Foods (Basel, Switzerland) · 2026Review
- Breaking the Black Box: Revolutionizing Traditional Chinese Medicine with Formula-Derived Nanoparticles.International journal of nanomedicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Traditional Chinese medicine (TCM), with its roots in centuries of clinical practice, has established itself as an effective therapeutic system that involves a diverse range of herbal plants. Despite its proven efficacy, the intricate relationships between herbal multi-component preparations and multi-target therapies present challenges for systematic study, thereby limiting its broader application in managing chronic diseases. In this work, we aim to identify novel therapeutic targets of natural compounds found in TCM herbs by leveraging advanced hypergraph representation learning techniques. Following the multi-component, multi-target pharmacological mechanisms, we first construct two hypergraphs to represent herb-compound and disease-target interactions, respectively. The connection between these hypergraphs is established through compound-target associations. A convolutional operator is then employed to capture the high-order correlations between compound (or target) nodes and herb (or disease) hyperedges within each hypergraph. Furthermore, we incorporate the PageRank algorithm and a multi-head attention mechanism to enhance the representation capabilities of node embeddings. By integrating these methods, our model is able to accurately identify novel therapeutic targets of natural compounds in TCM herbs in an end-to-end manner. Extensive experiments conducted on three benchmark datasets demonstrate the superior performance of our model when compared with several state-of-the-art approaches. Furthermore, case studies on two natural compounds, coumarin and progesterone, reveal that 7 and 8 out of the Top-10 identified targets, respectively, have been validated through literature review. These results highlight the effectiveness of our model in discovering new therapeutic targets for natural compounds in TCM.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.